Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

China flag China · Delayed Price · Currency is CNY
41.56
-2.01 (-4.61%)
Jul 3, 2026, 3:00 PM CST
Market Cap4.15B +107.7%
Revenue (ttm)443.29M -20.2%
Net Income-295.33M
EPS-2.97
Shares Out 99.88M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,060,401
Open43.39
Previous Close43.57
Day's Range41.36 - 43.57
52-Week Range19.91 - 46.92
Beta0.54
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:603139

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 1999 and is based in Xianyang, China. [Read more]

Sector Healthcare
Founded 1999
Employees 804
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603139
Full Company Profile

Financial Performance

In 2025, SHA:603139's revenue was 471.29 million, a decrease of -16.09% compared to the previous year's 561.63 million. Losses were -333.45 million, 272.1% more than in 2024.

Financial Statements